Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019;8(1):153-154.
doi: 10.1016/j.jcmgh.2019.04.006. Epub 2019 May 15.

NO to Lysosomes: A Signal for Insulin Resistance in Obesity

Ali Javaheri  1 , Abhinav Diwan  2
Affiliations
Editorial

NO to Lysosomes: A Signal for Insulin Resistance in Obesity

Ali Javaheri et al. Cell Mol Gastroenterol Hepatol. 2019.
No abstract available

PubMed Disclaimer

Comment on

  • Hepatic Lysosomal iNOS Activity Impairs Autophagy in Obesity.
    Qian Q, Zhang Z, Li M, Savage K, Cheng D, Rauckhorst AJ, Ankrum JA, Taylor EB, Ding WX, Xiao Y, Cao HJ, Yang L. Qian Q, et al. Cell Mol Gastroenterol Hepatol. 2019;8(1):95-110. doi: 10.1016/j.jcmgh.2019.03.005. Epub 2019 Mar 27. Cell Mol Gastroenterol Hepatol. 2019. PMID: 30926581 Free PMC article.

Similar articles

See all similar articles

References

    1. Qian Q., Zhang Z., Li M., Savage K., Cheng D., Rauckhorst A.J., Ankrum J.A., Taylor E.B., Ding W-x, Xiao Y., Cao H-j, Yang L. Hepatic lysosomal iNOS activity impairs autophagy in obesity. Cell Mol Gastroenterol Hepatol. 2019;8:95–110. - PMC - PubMed
    2. Qian Q, Zhang Z, Li M, Savage K, Cheng D, Rauckhorst AJ, Ankrum JA, Taylor EB, Ding W-x, Xiao Y, Cao H-j, Yang L. Hepatic lysosomal iNOS activity impairs autophagy in obesity. Cell Mol Gastroenterol Hepatol 2019;8:95–110. - PMC - PubMed
    1. Qian Q., Zhang Z., Orwig A., Chen S., Ding W.X., Xu Y., Kunz R.C., Lind N.R.L., Stamler J.S., Yang L. S-nitrosoglutathione reductase dysfunction contributes to obesity-associated hepatic insulin resistance via regulating autophagy. Diabetes. 2018;67:193–207. - PMC - PubMed
    2. Qian Q, Zhang Z, Orwig A, Chen S, Ding WX, Xu Y, Kunz RC, Lind NRL, Stamler JS, Yang L. S-nitrosoglutathione reductase dysfunction contributes to obesity-associated hepatic insulin resistance via regulating autophagy. Diabetes 2018;67:193-207. - PMC - PubMed
    1. Jia L., Wang Y., Wang Y., Ma Y., Shen J., Fu Z., Wu Y., Su S., Zhang Y., Cai Z., Wang J., Xiang M. Heme oxygenase-1 in macrophages drives septic cardiac dysfunction via suppressing lysosomal degradation of inducible nitric oxide synthase. Circ Res. 2018;122:1532–1544. - PubMed
    2. Jia L, Wang Y, Wang Y, Ma Y, Shen J, Fu Z, Wu Y, Su S, Zhang Y, Cai Z, Wang J, Xiang M. Heme oxygenase-1 in macrophages drives septic cardiac dysfunction via suppressing lysosomal degradation of inducible nitric oxide synthase. Circ Res 2018;122:1532-1544. - PubMed
    1. Liu H., Javaheri A., Godar R.J., Murphy J., Ma X., Rohatgi N., Mahadevan J., Hyrc K., Saftig P., Marshall C., McDaniel M.L., Remedi M.S., Razani B., Urano F., Diwan A. Intermittent fasting preserves beta-cell mass in obesity-induced diabetes via the autophagy-lysosome pathway. Autophagy. 2017;13:1952–1968. - PMC - PubMed
    2. Liu H, Javaheri A, Godar RJ, Murphy J, Ma X, Rohatgi N, Mahadevan J, Hyrc K, Saftig P, Marshall C, McDaniel ML, Remedi MS, Razani B, Urano F, Diwan A. Intermittent fasting preserves beta-cell mass in obesity-induced diabetes via the autophagy-lysosome pathway. Autophagy 2017;13:1952-1968. - PMC - PubMed
    1. Ma X., Mani K., Liu H., Kovacs A., Murphy J.T., Foroughi L., French B.A., Weinheimer C.J., Kraja A., Benjamin I.J., Hill J.A., Javaheri A., Diwan A. Transcription factor EB activation rescues advanced alphaB-crystallin mutation-induced cardiomyopathy by normalizing desmin localization. JAMA. 2019;8:e010866. - PMC - PubMed
    2. Ma X, Mani K, Liu H, Kovacs A, Murphy JT, Foroughi L, French BA, Weinheimer CJ, Kraja A, Benjamin IJ, Hill JA, Javaheri A, Diwan A. Transcription factor EB activation rescues advanced alphaB-crystallin mutation-induced cardiomyopathy by normalizing desmin localization. JAMA 2019;8:e010866. - PMC - PubMed

Publication types